CoChat

In Vitro Nonalcoholic Fatty Liver Disease Model Elucidating the Effect of Immune Environment on Disease Progression and Alleviation

Open access

The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.

Abstract

Nonalcoholic fatty liver disease (NAFLD), which is a major cause of chronic liver disease, is characterized by fat accumulation in the liver. Existing models struggle to assess medication effects on liver function in the context of NAFLD's unique inflammatory environment. We address this by developing a 3D in vitro NAFLD model using HepG2 and THP-1 cells (mimicking liver and Kupffer cells) cocultured using transwell and hydrogel system. This mimics liver architecture and allows for manipulation of the immune environment. We demonstrate that the model recapitulates key NAFLD features: steatosis (induced by fatty acids), oxidative stress, inflammation, and impaired liver function embodying the interrelationship between NAFLD and the surrounding immune environment. This versatile model offers a valuable tool for preclinical NAFLD research by incorporating a disease-relevant immune environment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1021/acsomega.4c02433

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Schematic diagram of the NAFLD in vitro model considering both hepatocyte and immune environments (created with BioRender.com).
Figure 1 Schematic diagram of the NAFLD in vitro model considering both hepatocyte and immune environments (created with BioRender.com).CC BY-NC-ND · PubMed Central
Figure 2 (a) Evaluation of the cellular viability across different concentrations of OA and PA. OA: PA of concentration: (5:2.5), (10:5), (20:10), (40:20), (80:40), (160:80), and (320:160) μM. “*”, “#”, “$”, “@”, “&”, “!”, and “%” indicate statistical significance in comparison with the vehicle control, (5:2.5), (10:5), (20:10), (40:20), (80:40), and (160:80) μM groups, respectively (p < 0.05). (b) ORO staining of HepG2 cells under various OAPA treatment conditions. Scale bars in the images are 20 μm (40× magnification).
Figure 2 (a) Evaluation of the cellular viability across different concentrations of OA and PA. OA: PA of concentration: (5:2.5), (10:5), (20:10), (40:20), (80:40), (160:80), and (320:160) μM. “*”, “#”, “$”, “@”, “&”, “!”, and “%” indicate statistical significance in comparison with the vehicle control, (5:2.5), (10:5), (20:10), (40:20), (80:40), and (160:80) μM groups, respectively (p < 0.05). (b) ORO staining of HepG2 cells under various OAPA treatment conditions. Scale bars in the images are 20 μm (40× magnification).CC BY-NC-ND · PubMed Central
Figure 3 Evaluation of lipid accumulation by ORO staining in THP-1 cocultures and OAPA treatment. (a) ORO stained phase contrast images of HepG2 cells upon the varied culture conditions (scale bars = 20 μm, 40× magnification). (b) Relative lipid intensities under various culture conditions. “*”, “#”, and “$” indicate statistical significance compared to HepG2 10:1_VC, HepG2 10:1_OAPA, and HepG2 10:5_VC groups, respectively (p < 0.05). (c) Relative ROS production by THP-1 upon the varied experimental conditions. “*”, “#”, and “$” indicate statistical significance compared to THP-1 10:1_VC, THP-1 10:1_OAPA, and THP-1 10:5_OAPA groups, respectively (p < 0.05).
Figure 3 Evaluation of lipid accumulation by ORO staining in THP-1 cocultures and OAPA treatment. (a) ORO stained phase contrast images of HepG2 cells upon the varied culture conditions (scale bars = 20 μm, 40× magnification). (b) Relative lipid intensities under various culture conditions. “*”, “#”, and “$” indicate statistical significance compared to HepG2 10:1_VC, HepG2 10:1_OAPA, and HepG2 10:5_VC groups, respectively (p < 0.05). (c) Relative ROS production by THP-1 upon the varied experimental conditions. “*”, “#”, and “$” indicate statistical significance compared to THP-1 10:1_VC, THP-1 10:1_OAPA, and THP-1 10:5_OAPA groups, respectively (p < 0.05).CC BY-NC-ND · PubMed Central
Figure 4 Expression levels of (a) inflammatory genes and (b) hepatic maturation markers in HepG2 cells after NAFLD induction. “*”, “#”, and “$” indicate statistical significance when compared to HepG2 10:1_VC, HepG2 10:1_OAPA, and HepG2 10:5_VC groups, respectively (p < 0.05).
Figure 4 Expression levels of (a) inflammatory genes and (b) hepatic maturation markers in HepG2 cells after NAFLD induction. “*”, “#”, and “$” indicate statistical significance when compared to HepG2 10:1_VC, HepG2 10:1_OAPA, and HepG2 10:5_VC groups, respectively (p < 0.05).CC BY-NC-ND · PubMed Central
Figure 5 Alleviation of induced NAFLD using prednisolone. (a) ORO staining images of HepG2 after NALFD induction and alleviation (scale bars = 20 μm). (b) Relative lipid intensity after NALFD induction and alleviation. “*” and “#” indicate statistical significance compared to the HepG2 10:5_VC and HepG2 10:5_OAPA groups, respectively (p < 0.05). (c) Relative ROS production by THP-1 cells after NALFD induction and alleviation. “*” and “#” indicate statistical significance when compared to the THP-1 10:5_VC and THP-1 10:5_OAPA groups, respectively (p < 0.05).
Figure 5 Alleviation of induced NAFLD using prednisolone. (a) ORO staining images of HepG2 after NALFD induction and alleviation (scale bars = 20 μm). (b) Relative lipid intensity after NALFD induction and alleviation. “*” and “#” indicate statistical significance compared to the HepG2 10:5_VC and HepG2 10:5_OAPA groups, respectively (p < 0.05). (c) Relative ROS production by THP-1 cells after NALFD induction and alleviation. “*” and “#” indicate statistical significance when compared to the THP-1 10:5_VC and THP-1 10:5_OAPA groups, respectively (p < 0.05).CC BY-NC-ND · PubMed Central
Figure 6 (a) Phase-contrast images of HepG2 cells cultured in D (left, scale bars = 20 μm) and encapsulated HepG2 spheroids within 3D GelMA hydrogels (right, scale bars = 50 μm). (b) Expression levels of genes associated with hepatocyte maturation in 2D and 3D cultures of HepG2 cells (*p < 0.05). (c) ORO-stained HepG2 spheroids in 3.5 wt % GelMA hydrogel under various NAFLD induction conditions (scale bars = 20 μm, 20× magnification). (d) Relative lipid intensity on the 3D HepG2 spheroids under various NAFLD induction conditions. “*”, “#”, and “$” indicate statistical significance compared to 3D HepG2 10:1_VC, 3D HepG2 10:1_OAPA, and 3D HepG2 10:5_VC groups, respectively (p < 0.05). (e) Relative ROS production by THP-1 upon the varied experimental conditions. “*”, “#”, and “$” indicate statistical significance compared to THP-1 10:1_VC, THP-1 10:1_OAPA, and THP-1 10:5_OAPA groups, respectively (p < 0.05).
Figure 6 (a) Phase-contrast images of HepG2 cells cultured in D (left, scale bars = 20 μm) and encapsulated HepG2 spheroids within 3D GelMA hydrogels (right, scale bars = 50 μm). (b) Expression levels of genes associated with hepatocyte maturation in 2D and 3D cultures of HepG2 cells (*p < 0.05). (c) ORO-stained HepG2 spheroids in 3.5 wt % GelMA hydrogel under various NAFLD induction conditions (scale bars = 20 μm, 20× magnification). (d) Relative lipid intensity on the 3D HepG2 spheroids under various NAFLD induction conditions. “*”, “#”, and “$” indicate statistical significance compared to 3D HepG2 10:1_VC, 3D HepG2 10:1_OAPA, and 3D HepG2 10:5_VC groups, respectively (p < 0.05). (e) Relative ROS production by THP-1 upon the varied experimental conditions. “*”, “#”, and “$” indicate statistical significance compared to THP-1 10:1_VC, THP-1 10:1_OAPA, and THP-1 10:5_OAPA groups, respectively (p < 0.05).CC BY-NC-ND · PubMed Central
Figure 7 (a) ORO staining images of 3D cultured HepG2 cells after NALFD induction and alleviation by prednisolone treatment (scale bars = 20 μm). (b) Relative lipid intensity after NALFD induction and alleviation. “*” and “#” indicate statistical significance compared to the HepG2 10:5_VC and HepG2 10:5_OAPA groups, respectively (p < 0.05). (c) Relative ROS production by THP-1 cells after NALFD induction and alleviation. “*” and “#” indicate statistical significance when compared to the THP-1 10:5_VC and THP-1 10:5_OAPA groups, respectively (p < 0.05).
Figure 7 (a) ORO staining images of 3D cultured HepG2 cells after NALFD induction and alleviation by prednisolone treatment (scale bars = 20 μm). (b) Relative lipid intensity after NALFD induction and alleviation. “*” and “#” indicate statistical significance compared to the HepG2 10:5_VC and HepG2 10:5_OAPA groups, respectively (p < 0.05). (c) Relative ROS production by THP-1 cells after NALFD induction and alleviation. “*” and “#” indicate statistical significance when compared to the THP-1 10:5_VC and THP-1 10:5_OAPA groups, respectively (p < 0.05).CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 40 references

Cited by

See all 10

Metadata

Authors
Kim, I., Kyun, M.-L., Jung, H., Kwon, J.-I., Kim, J., Kim, J.-K., Lee, Y. B., Kwon, Y.-I., & Moon, K.-S.
Affiliations
  • Hannam University (KR)
  • Korea Institute of Toxicology (KR)
Corresponding author
  • Lee, Yu Bin
  • Kwon, Young-In
  • Moon, Kyoung-Sik
Venue
ACS Omega
Published
2024-05-27
Volume
9
Issue
23
Pages
25094-25105
ISSN
2470-1343 (ISSN-L)
OpenAlex
W4399055201
Cited by
10
References
40
Citations by year
2026: 5 · 2025: 4 · 2024: 1
FWCI
3.03
Type
journal article
Language
en
Open access
Locations
  • ACS Omega (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Korea Institute of Toxicology (1711195891)
Topics
  • Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
Keywords
non-alcoholic fatty liver disease, 3D in vitro model, HepG2 cells, THP-1 cells, Kupffer cells, co-culture, hydrogels, transwell assay, steatosis, oxidative stress, liver inflammation, fatty acids, liver function

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.